Genetic Determinants and Clinical Consequences of Early-onset Severe Obesity
NCT ID: NCT02645422
Last Updated: 2023-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2015-12-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetics of Fatty Liver Disease in Children
NCT01966627
Genetic Research of Monogenic Obesity in a Pediatric Cohort With Severe and Early Onset Obesity
NCT05362565
Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight
NCT00823277
Personalised Medicine for Morbid Obesity
NCT01365416
Sequencing of 14 Genes From Leptin Melanocortin Pathway in Severe Obesity in Childhood.
NCT05938335
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aims of this study are to determine
* inheritance patterns of early-onset obesity
* new obesity-related genetic variants and disease-causing gene mutations
* the association between obesity-related genetic defects and clinical manifestations
* the association between obesity-related genetic defects and psychiatric symptoms
in patients with early-onset obesity and their first-degree relatives
Significant advancements in genetic methodology provide new tools to explore genetic defects underlying obesity. Family-based approach provides several advantages compared to cohort studies to investigate genetic determinants of complex diseases.The unique genetic composition of the Finnish population enables identification of novel genetic entities.
Discovery of genetic defects associated with severe childhood-onset obesity will increase the investigators understanding of the pathogenesis of obesity and allows early detection, by genetic testing, of those at increased risk and optimal targeting of preventive measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* height-adjusted weight \>60 % before the age of 7 years.
* Finnish descent
Exclusion Criteria
10 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Folkhälsan Researech Center
OTHER
Karolinska Institutet
OTHER
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Petra Loid
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Outi Mäkitie, Prof.
Role: STUDY_DIRECTOR
Helsinki University Central Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUCH43/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.